Back
bluebird bio Vs. Protalix BioTherapeutics Industry Stock Comparison
Sell
22
BLUE
bluebird bio
Last Price:
$8.23
Seasonality Move:
-8.48%
Buy
68
PLX
Protalix BioTherapeutics
Last Price:
$1.76
Seasonality Move:
19.62%
Sell
22
bluebird bio (BLUE)
is a Sell
Is bluebird bio a Buy, Sell or Hold?
-
The current bluebird bio [BLUE] share price is $8.43. The Score for BLUE is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
BLUE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy, Sell or Hold?
-
The current Protalix BioTherapeutics [PLX] share price is $1.76. The Score for PLX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
PLX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BLUE Stock Price Chart
What is bluebird bio's stock price today?
-
The bluebird bio share price today is $8.43Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLUE is experiencing slight selling pressure.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.76Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing slight buying pressure.
BLUE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 50.22 | Buy |
Chaikin Money Flow: | -425188 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.24 - 9.66) | Buy |
Bollinger Bands (100): | (7.16 - 14.48) | Sell |
PLX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 63.36 | Buy |
Chaikin Money Flow: | 163099 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.62 - 1.78) | Buy |
Bollinger Bands (100): | (0.93 - 1.51) | Buy |
BLUE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.08 | Buy |
20-day SMA: | 8.37 | Buy |
50-day SMA: | 8.58 | Sell |
200-day SMA: | 16.25 | Sell |
8-day EMA: | 8.44 | Sell |
20-day EMA: | 8.34 | Buy |
50-day EMA: | 8.96 | Sell |
200-day EMA: | 18.9 | Sell |
PLX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.76 | Sell |
20-day SMA: | 1.72 | Buy |
50-day SMA: | 1.43 | Buy |
200-day SMA: | 1.21 | Buy |
8-day EMA: | 1.75 | Buy |
20-day EMA: | 1.69 | Buy |
50-day EMA: | 1.5 | Buy |
200-day EMA: | 1.32 | Buy |
bluebird bio Earnings Growth & BLUE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $5.56 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.31 per share, and an increase next year of $16.11 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
bluebird bio Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Protalix BioTherapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |